Status:
UNKNOWN
Analysis of Prognostic and Predictive Genomic Signatures Using Archival Paraffin-embedded Breast Tumor - a Pilot Study
Lead Sponsor:
National University Hospital, Singapore
Conditions:
Breast Tumor
Eligibility:
FEMALE
Brief Summary
A number of prognostic and/or predictive genomic signatures for breast cancer have been developed by Genome Institute of Singapore (GIS). In the past 1 year, GIS has developed protocols and methods to...
Detailed Description
Up to 10 archival breast tumor blocks will be obtained from the Department of Pathology, NUH - half of these blocks will be from patients who were diagnosed before year 2000, and the other half of the...
Eligibility Criteria
Inclusion
- Half of these blocks will be from breast cancer patients who were diagnosed before year 2000.
- Half of the blocks will be from breast cancer patients diagnosed between year 2000-2005 (control specimens).
Exclusion
- Breast cancer patients diagnosed after year 2005.
Key Trial Info
Start Date :
August 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2014
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01247467
Start Date
August 1 2010
End Date
December 1 2014
Last Update
January 22 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National University Hospital
Singapore, Singapore, Singapore